#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Monogenic diabetes Behcet's syndrome Progressive multifocal leukoencephalopathy Hepatitis B Glomerulonephritis membranoproliferative Staphylococcal infection T-cell lymphoma Angiosarcoma metastatic Neonatal asphyxia Pancreatic carcinoma metastatic Progressive familial intrahepatic cholestasis Retinoblastoma Congenital pseudarthrosis Friedreich's ataxia Glioblastoma multiforme More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Treatment Sarcoidosis Rhabdomyosarcoma recurrent – Treatment SAPHO syndrome – Life with Disease Cystic fibrosis – Trials in Disease Hepatoblastoma – Life with Disease Hepatoblastoma Sarcoidosis – Treatment Chondrosarcoma – Life with Disease Mantle cell lymphoma refractory – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Esomeprazole Magnesium Rosuvastatin Cloxacillin Sodium Sodium Thiosulfate Aficamten Plerixafor For-6219 Sar441566 Esk-001 GVV858 Ursodoxicoltaurine Fluticasone Furoate Tafluprost Micafungin Quavonlimab Vosilasarm Empagliflozin Repagermanium Mosaic Hbcoreag Itolizumab More therapies…

    Learn about Your Condition

    Right ventricular dysfunction Triple negative breast cancer Rectal cancer Arterial tortuosity syndrome Medulloblastoma Endocarditis bacterial Tricuspid valve disease Lichen planopilaris Decreased appetite Catatonia Bronchopulmonary dysplasia Multiple system atrophy Nocturia Hepatic cirrhosis Arrhythmia supraventricular More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on the Effects of Tedizolid and Linezolid for Patients with Suspected Lung Tuberculosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ethambutol
    • Linezolid
    • Tedizolid Phosphate
    France

  • Study of caspofungin compared to placebo for treating yeast infections in the abdomen in intensive care unit patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peritonitis
    • Fungal infection
    Investigated Drugs:
    • Caspofungin
    • Sodium Chloride
    France

  • Study on E. coli Polysaccharide for Reducing Antibiotic Use in Patients with Neurogenic Bladder and Recurrent Urinary Tract Infections

    Recruiting

    3 1 1
    Investigated Diseases:
    • Neurogenic bladder
    Investigated Drugs:
    • E.coli Polysaccharide
    France

  • Study on Antibiotic Prophylaxis with Piperacillin, Tazobactam, and Cefazolin for Burn Patients Undergoing Excision-Graft Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Cefazolin
    • Piperacillin Sodium
    • Tazobactam Sodium
    France

  • Study on Amoxicillin and Clavulanic Acid for Treating Ventilator-Associated Pneumonia in Intensive Care Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    France

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Betamethasone Valerate
    • CEFTAROLINE FOSAMIL
    France
Previous Page
1 … 10 11 12 13 14 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!